tiprankstipranks
Trending News
More News >
Mister Spex SE (DE:MRX)
:MRX

Mister Spex SE (MRX) AI Stock Analysis

Compare
8 Followers

Top Page

DE

Mister Spex SE

(XETRA:MRX)

Rating:47Neutral
Price Target:
€1.50
▼(-2.60%Downside)
Mister Spex SE is currently facing financial difficulties, characterized by declining revenues and negative profitability metrics. The technical indicators provide some near-term support but do not mitigate the long-term financial challenges. Valuation metrics further detract from the stock's attractiveness, with a negative P/E ratio and no dividend yield. These factors combine to result in a low overall stock score, requiring significant improvements in financial performance for a more favorable outlook.

Mister Spex SE (MRX) vs. iShares MSCI Germany ETF (EWG)

Mister Spex SE Business Overview & Revenue Model

Company DescriptionMister Spex SE is a leading European online eyewear retailer based in Germany, specializing in the sale of prescription glasses, sunglasses, and contact lenses. The company operates in the e-commerce sector and combines its digital offerings with a network of physical stores and partner opticians, providing a comprehensive range of eyewear products and services to its customers.
How the Company Makes MoneyMister Spex SE generates revenue primarily through the sale of eyewear products such as prescription glasses, sunglasses, and contact lenses via its online platform and physical retail locations. Key revenue streams include direct online sales to consumers, in-store purchases at its brick-and-mortar locations, and services offered through its partner optician network, which allows customers to access eye tests and fitting services. The company benefits from significant partnerships with well-known eyewear brands, enhancing its product offerings and attracting a wide customer base. Additionally, Mister Spex SE's integration of digital and physical retail channels provides a seamless shopping experience, encouraging repeat purchases and customer loyalty.

Mister Spex SE Financial Statement Overview

Summary
Mister Spex SE faces significant financial challenges, with declining revenues, persistent losses, and negative cash flow metrics. The company struggles with high operational expenses and low profitability, and while the balance sheet shows moderate leverage, the overall financial health is constrained by negative returns and poor cash flow performance.
Income Statement
45
Neutral
Mister Spex SE shows declining revenue with a revenue growth rate of -2.96% from the previous year (2023 to 2024). The company has a negative gross profit margin of 29.06% TTM, indicating challenges in managing cost of goods sold. Profitability metrics are weak with a net profit margin of -38.96% TTM, and both EBIT and EBITDA margins are negative, reflecting ongoing operational and financial struggles.
Balance Sheet
50
Neutral
The debt-to-equity ratio stands at 0.98 TTM, indicating moderate leverage. However, the return on equity is negative at -125.33% TTM, largely due to significant net losses. The equity ratio is somewhat stable at 39.96% TTM, suggesting a reasonable proportion of equity financing relative to total assets.
Cash Flow
40
Negative
Cash flow metrics indicate financial stress, with a negative free cash flow growth rate of -16.20% from 2023 to 2024. The operating cash flow to net income ratio is unfavorable at 0.17 TTM, and the free cash flow to net income ratio is also negative. These reflect challenges in generating sufficient cash from operations to cover net losses.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
210.34M216.75M223.53M210.07M194.25M164.20M
Gross Profit
61.17M111.22M24.81M108.73M101.86M85.51M
EBIT
-45.11M-48.06M-28.17M-30.29M-24.07M-5.26M
EBITDA
-25.99M-51.02M-9.62M-14.07M-8.48M5.77M
Net Income Common Stockholders
-81.96M-84.86M-47.88M-44.93M-31.52M-10.26M
Balance SheetCash, Cash Equivalents and Short-Term Investments
23.30M73.08M111.15M128.30M178.08M14.68M
Total Assets
0.00171.27M306.48M293.23M325.32M122.74M
Total Debt
0.0066.35M86.61M61.66M51.69M67.69M
Net Debt
23.30M-5.78M-24.05M-66.14M-97.95M53.16M
Total Liabilities
0.0099.43M151.02M92.23M80.53M89.33M
Stockholders Equity
29.15M71.84M155.45M201.00M244.78M33.41M
Cash FlowFree Cash Flow
-19.00M-22.68M-8.57M-40.52M-43.67M-15.39M
Operating Cash Flow
-13.71M-16.30M6.04M-20.84M-27.82M-1.55M
Investing Cash Flow
-5.29M-6.38M-14.61M3.75M-40.93M-17.06M
Financing Cash Flow
-16.32M-15.85M-8.57M-4.76M203.86M9.86M

Mister Spex SE Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.54
Price Trends
50DMA
1.43
Positive
100DMA
1.53
Negative
200DMA
1.77
Negative
Market Momentum
MACD
0.03
Negative
RSI
52.43
Neutral
STOCH
42.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:MRX, the sentiment is Neutral. The current price of 1.54 is above the 20-day moving average (MA) of 1.49, above the 50-day MA of 1.43, and below the 200-day MA of 1.77, indicating a neutral trend. The MACD of 0.03 indicates Negative momentum. The RSI at 52.43 is Neutral, neither overbought nor oversold. The STOCH value of 42.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DE:MRX.

Mister Spex SE Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
DEFIE
74
Outperform
€4.58B30.15
1.79%
DEPUM
69
Neutral
$3.22B16.617.25%2.57%3.22%-28.92%
63
Neutral
$6.96B11.512.80%3.85%2.70%-24.43%
DEHFG
57
Neutral
€1.61B-20.86%-1.77%-361.24%
DELXS
57
Neutral
$2.37B-3.92%0.36%-5.18%-139.96%
DEMRX
47
Neutral
€51.91M-74.67%-3.03%-76.50%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:MRX
Mister Spex SE
1.52
-1.48
-49.33%
DE:PUM
PUMA SE NPV
22.96
-23.09
-50.14%
DE:HFG
HelloFresh SE
9.41
3.81
68.04%
DE:FIE
Fielmann
54.60
11.89
27.84%
DE:LXS
LANXESS
27.40
4.92
21.86%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.